BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7833251)

  • 1. Altered platelet phospholipid-dependent thrombin generation in thrombocytopenia and thrombocytosis.
    Lee LH; Baglin T
    Br J Haematol; 1995 Jan; 89(1):131-6. PubMed ID: 7833251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of procoagulant potential in patients with reactive thrombocytosis and its association with platelet count.
    Rottenstreich A; Shai E; Kleinstern G; Spectre G; Varon D; Kalish Y
    Eur J Haematol; 2018 Mar; 100(3):286-293. PubMed ID: 29240268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet disorders: an overview.
    Krishnegowda M; Rajashekaraiah V
    Blood Coagul Fibrinolysis; 2015 Jul; 26(5):479-91. PubMed ID: 26126029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelets and phospholipids in tissue factor-initiated thrombin generation.
    Butenas S; Branda RF; van't Veer C; Cawthern KM; Mann KG
    Thromb Haemost; 2001 Aug; 86(2):660-7. PubMed ID: 11522019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is platelet phospholipid-dependent thrombin generation altered by acute myocardial infarction or aspirin?
    Rota S; Flynn PD; Wareham NJ; Baglin TP; Byrne CD
    Thromb Res; 1996 Aug; 83(4):329-38. PubMed ID: 8870177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formation.
    Gerotziafas GT; Chakroun T; Depasse F; Arzoglou P; Samama MM; Elalamy I
    Thromb Haemost; 2004 May; 91(5):977-85. PubMed ID: 15116259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reticulated platelets are increased in chronic myeloproliferative disorders, pure erythrocytosis, reactive thrombocytosis and prior to hematopoietic reconstitution after intensive chemotherapy.
    Ryningen A; Apelseth T; Hausken T; Bruserud Ø
    Platelets; 2006 Aug; 17(5):296-302. PubMed ID: 16928601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble platelet glycoprotein V in distinct disease states of pathological thrombopoiesis.
    Acar K; Aksu S; Beyazit Y; Haznedaroglu IC; Koca E; Cetiner D; Sayinalp N; Buyukasik Y; Goker H; Kirazli S; Ozcebe OI
    J Natl Med Assoc; 2008 Jan; 100(1):86-90. PubMed ID: 18277814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum thrombopoietin level is not regulated by transcription but by the total counts of both megakaryocytes and platelets during thrombocytopenia and thrombocytosis.
    Nagata Y; Shozaki Y; Nagahisa H; Nagasawa T; Abe T; Todokoro K
    Thromb Haemost; 1997 May; 77(5):808-14. PubMed ID: 9184382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin generation and procoagulant phospholipids in patients with essential thrombocythemia and reactive thrombocytosis.
    Mignon I; Grand F; Boyer F; Hunault-Berger M; Hamel JF; Macchi L
    Am J Hematol; 2013 Dec; 88(12):1007-11. PubMed ID: 23873831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma heparin neutralizing activity. Its use in the evaluation of thrombocytopenia and thrombocytosis.
    Dana B; Carvalho AC; Ellman L
    Am J Clin Pathol; 1976 Jun; 65(6):964-9. PubMed ID: 945687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin generation in patients with cirrhosis: the role of platelets.
    Tripodi A; Primignani M; Chantarangkul V; Clerici M; Dell'Era A; Fabris F; Salerno F; Mannucci PM
    Hepatology; 2006 Aug; 44(2):440-5. PubMed ID: 16871542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Megakaryocytic responses to thrombocytopenia and thrombocytosis in Sl/Sld mice.
    Ebbe S; Phalen E; D'Amore P; Howard D
    Exp Hematol; 1978 Feb; 6(2):201-12. PubMed ID: 627255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet apoptosis and agonist-mediated activation in myelodysplastic syndromes.
    Martín M; de Paz R; Jiménez-Yuste V; Fernández Bello I; García Arias Salgado E; Alvarez MT; Butta NV
    Thromb Haemost; 2013 May; 109(5):909-19. PubMed ID: 23407717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia-like conditions in a cell-based model system.
    Kjalke M; Ezban M; Monroe DM; Hoffman M; Roberts HR; Hedner U
    Br J Haematol; 2001 Jul; 114(1):114-20. PubMed ID: 11472355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet phospholipids in thrombocytosis due to myeloproliferative disorders.
    Breuer JH; Harsányi V; Solti V; Hollán SR
    Haemostasis; 1981; 10(3):134-40. PubMed ID: 7262643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On thrombocyte counts in the dog].
    Kammermann-Lüscher B
    Schweiz Arch Tierheilkd; 1970 Nov; 112(11):588-605. PubMed ID: 4930836
    [No Abstract]   [Full Text] [Related]  

  • 18. [Thrombocytosis and thrombocytopenia - background and clinical relevance].
    Wille K; Sadjadian P; Griesshammer M
    Dtsch Med Wochenschr; 2017 Nov; 142(23):1732-1743. PubMed ID: 29145678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumonia.
    Mirsaeidi M; Peyrani P; Aliberti S; Filardo G; Bordon J; Blasi F; Ramirez JA
    Chest; 2010 Feb; 137(2):416-20. PubMed ID: 19837825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet procoagulant complex assembly in a tissue factor-initiated system.
    Monroe DM; Roberts HR; Hoffman M
    Br J Haematol; 1994 Oct; 88(2):364-71. PubMed ID: 7803283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.